The present invention provides substituted imidazopyridines as described herein or a pharmaceutically acceptable salt or solvate thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.本發明提供如本文所闡述之經取代咪唑吡啶或其醫藥上可接受之鹽或溶劑合物。代表性化合物可用作HDM2蛋白之抑制劑。亦揭示包括該等上述化合物之醫藥組合物及使用其治療癌症之潛在方法。